{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:11:25Z","timestamp":1778940685813,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,16]]},"DOI":"10.7759\/cureus.108969","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:53:01Z","timestamp":1778939581000},"source":"Crossref","is-referenced-by-count":0,"title":["A Missed Clue in Plain Sight: Hyperproteinemia and Nonlytic Skeletal Disease Revealing Immunoglobulin A Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Alireza","family":"Izadian Bidgoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Gomez Veliz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25876","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Erratum","volume":"95","author":"Rajkumar SV","year":"2020","unstructured":"Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Erratum. Am J Hematol. 2020, 95:1444. 10.1002\/ajh.25876","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.498","article-title":"Management of multiple myeloma in the newly diagnosed patient","volume":"2017","author":"Mateos MV","year":"2017","unstructured":"Mateos MV, San Miguel JF. Management of multiple myeloma in the newly diagnosed patient. Hematology Am Soc Hematol Educ Program. 2017, 2017:498-507. 10.1182\/asheducation-2017.1.498","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.231513","article-title":"IgA type multiple myeloma, clinical features, and prognosis","volume":"131","author":"Wang L","year":"2018","unstructured":"Wang L, Jin FY, Li Y, Sun JN, Zhang JJ, Tang R, Zhong YP. IgA type multiple myeloma, clinical features, and prognosis. Chin Med J (Engl). 2018, 131:1249-50. 10.4103\/0366-6999.231513","journal-title":"Chin Med J (Engl)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0018-y","article-title":"The multiple myelomas - current concepts in cytogenetic classification and therapy","volume":"15","author":"Kumar SK","year":"2018","unstructured":"Kumar SK, Rajkumar SV. The multiple myelomas - current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol. 2018, 15:409-21. 10.1038\/s41571-018-0018-y","journal-title":"Nat Rev Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2009.01.005","article-title":"Management of complications in multiple myeloma","volume":"46","author":"Terpos E","year":"2009","unstructured":"Terpos E, Cibeira MT, Blade J, Ludwig H. Management of complications in multiple myeloma. Semin Hematol. 2009, 46:176-89. 10.1053\/j.seminhematol.2009.01.005","journal-title":"Semin Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle RA","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008, 111:2962-72. 10.1182\/blood-2007-10-078022","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016","volume":"4","author":"Cowan AJ","year":"2018","unstructured":"Cowan AJ, Allen C, Barac A, et al.. Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016. JAMA Oncol. 2018, 4:1221-7. 10.1001\/jamaoncol.2018.2128","journal-title":"JAMA Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian D","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol. 2016, 43:676-81. 10.1053\/j.seminoncol.2016.11.004","journal-title":"Semin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2009.134","article-title":"Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis","volume":"23","author":"Landgren","year":"2009","unstructured":"Landgren, O., Weiss, B. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis. Leukemia. 2009, 23:1691-7.","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos E","year":"2021","unstructured":"Terpos E, Zamagni E, Lentzsch S, et al.. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group. Lancet Oncol. 2021, 22:e119-30. 10.1016\/S1470-2045(20)30559-3","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1585842","article-title":"The colorful landscape of multiple myeloma","volume":"60","author":"Muchtar E","year":"2019","unstructured":"Muchtar E, Gertz MA. The colorful landscape of multiple myeloma. Leuk Lymphoma. 2019, 60:2099-100. 10.1080\/10428194.2019.1585842","journal-title":"Leuk Lymphoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-825331","article-title":"Toward personalized treatment in multiple myeloma based on molecular characteristics","volume":"133","author":"Pawlyn C","year":"2019","unstructured":"Pawlyn C, Davies FE. Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood. 2019, 133:660-75. 10.1182\/blood-2018-09-825331","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5969","article-title":"A case of multiple myeloma presenting with gastrointestinal bleeding and Evans syndrome","volume":"11","author":"Khan MS","year":"2019","unstructured":"Khan MS, Kasmani R, Khan G, Changal K, Singh H. A case of multiple myeloma presenting with gastrointestinal bleeding and Evans syndrome. Cureus. 2019, 11:e5969. 10.7759\/cureus.5969","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58010134","article-title":"Duodenal ulcer with massive gastrointestinal hemorrhage as an initial manifestation in multiple myeloma with extramedullary disease: a case report","volume":"58","author":"Chiu HT","year":"2022","unstructured":"Chiu HT, Chen PH, Yen H, et al.. Duodenal ulcer with massive gastrointestinal hemorrhage as an initial manifestation in multiple myeloma with extramedullary disease: a case report. Medicina (Kaunas). 2022, 58:10.3390\/medicina58010134","journal-title":"Medicina (Kaunas)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2021.08.006","article-title":"Pathogenesis and treatment of multiple myeloma bone disease","volume":"57","author":"Hiasa M","year":"2021","unstructured":"Hiasa M, Harada T, Tanaka E, Abe M. Pathogenesis and treatment of multiple myeloma bone disease. Jpn Dent Sci Rev. 2021, 57:164-73. 10.1016\/j.jdsr.2021.08.006","journal-title":"Jpn Dent Sci Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2022.13.5.11","article-title":"A focus on relapsed multiple myeloma","volume":"13","author":"Noonan K","year":"2022","unstructured":"Noonan K, Rome S, Faiman B. A focus on relapsed multiple myeloma. J Adv Pract Oncol. 2022, 13:15-21. 10.6004\/jadpro.2022.13.5.11","journal-title":"J Adv Pract Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495446-a-missed-clue-in-plain-sight-hyperproteinemia-and-nonlytic-skeletal-disease-revealing-immunoglobulin-a-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:53:02Z","timestamp":1778939582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495446-a-missed-clue-in-plain-sight-hyperproteinemia-and-nonlytic-skeletal-disease-revealing-immunoglobulin-a-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.108969","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}